Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$25.33 - $34.25 $886 - $1,198
-35 Reduced 5.09%
652 $19,000
Q1 2022

May 11, 2022

SELL
$28.51 - $32.9 $199 - $230
-7 Reduced 1.01%
687 $22,000
Q3 2021

Nov 24, 2021

BUY
$23.54 - $31.39 $823 - $1,098
35 Added 5.31%
694 $19,000
Q2 2020

Jul 10, 2020

BUY
$17.09 - $24.89 $222 - $323
13 Added 2.01%
659 $16,000
Q1 2020

Apr 15, 2020

SELL
$14.45 - $24.69 $5,115 - $8,740
-354 Reduced 35.4%
646 $12,000
Q2 2019

Aug 07, 2019

BUY
$29.96 - $38.87 $29,960 - $38,870
1,000 New
1,000 $33,000
Q1 2019

Apr 29, 2019

SELL
$32.77 - $41.99 $0 - $0
0 Closed
0 $0
Q4 2018

Feb 04, 2019

BUY
$30.84 - $49.51 $0 - $0
0 New
0 $0

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.93B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.